PPE17 (Rv1168c) protein of Mycobacterium tuberculosis detects individuals with latent TB infection
- PMID: 30475863
- PMCID: PMC6261109
- DOI: 10.1371/journal.pone.0207787
PPE17 (Rv1168c) protein of Mycobacterium tuberculosis detects individuals with latent TB infection
Abstract
Latent tuberculosis infection (LTBI) is a clinically distinct category of Mycobacterium tuberculosis (Mtb) infection that needs to be diagnosed at the initial stage. We have reported earlier that one of the Mtb proline-proline-glutamic acid (PPE) proteins, PPE17 (Rv1168c) is associated with stronger B-cell and T-cell responses and could be used to diagnose different clinical categories of active TB patients with higher specificity and sensitivity than PPD and ESAT-6. Based on these observations we further tested the potential of PPE17 for the diagnosis of LTBI. We tested 198 sera samples collected from LTBI individuals (n = 61), QFT-negative (n = 58) and active TB patients (n = 79). Individuals were defined as LTBI by QuantiFERON-TB Gold In-Tube test (QFT-GIT) positive results, while active TB patients were confirmed based on the guidelines of the Revised National TB Control Programme of India. The antibody responses against PPE17, ESAT-6:CFP-10 and PPD were compared in these subjects by enzyme-linked immunosorbent assay. We observed that LTBI individuals show a higher sero-reactivity to PPE17 as compared to currently used latent TB diagnostic antigens like ESAT-6, CFP-10 and PPD. The LTBI and active TB patients display almost similar sensitivity. Interestingly, PPE17 could discriminate LTBI positive subjects from the QFT-negative subjects (P < 0.001). Our study hints that PPE17 may be used as a novel serodiagnostic marker to screen the latently infected subjects and may also be used as a complimentary tool to the QFT-GIT.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- World Health Organization. Global tuberculosis report 2017. Available at: http://apps.who.int/iris/bitstream/10665/259366/1/9789241565516-eng.pdf?.... Accessed 20 October 2017.
-
- World Health Organization. Latent TB infection fact sheet 2014. Available at: http://www.who.int/tb/challenges/ltbi_factsheet_2014.pdf?ua=1. Accessed 20 May 2016.
-
- Houben RMGJ Dodd PJ. The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling. PLoS Med 2016; 13:e1002152 10.1371/journal.pmed.1002152 - DOI - PMC - PubMed
-
- Perez-Porcuna TM, Pereira-da-Silva HD, Ascaso C, Malheiro A, Bührer S, Martinez-Espinosa F, et al. Prevalence and diagnosis of latent tuberculosis infection in young children in the absence of a gold standard. PLoS One 2016; 11:e0164181 10.1371/journal.pone.0164181 - DOI - PMC - PubMed
-
- Centers for Disease Control and Prevention. Latent tuberculosis infection: A guide for primary health care providers, 2013. Available at: http://www.cdc.gov/tb/publications/LTBI/pdf/TargetedLTBI.pdf. Accessed 24 July 2016.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
